Freestone Capital Holdings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.7M | Sell |
29,810
-359
| -1% | -$195K | 0.44% | 38 |
|
|
2025
Q4 | $17.5M | Buy |
30,169
+82
| +0.3% | +$46.4K | 0.52% | 34 |
|
|
2025
Q3 | $14.6M | Buy |
30,087
+952
| +3% | +$443K | 0.45% | 38 |
|
|
2025
Q2 | $11.8M | Buy |
29,135
+1,771
| +6% | +$740K | 0.4% | 46 |
|
|
2025
Q1 | $13.6M | Buy |
27,364
+1,167
| +4% | +$632K | 0.51% | 34 |
|
|
2024
Q4 | $13.6M | Sell |
26,197
-348
| -1% | -$191K | 0.47% | 38 |
|
|
2024
Q3 | $16.4M | Buy |
26,545
+354
| +1% | +$210K | 0.56% | 32 |
|
|
2024
Q2 | $14.5M | Buy |
26,191
+530
| +2% | +$304K | 0.52% | 32 |
|
|
2024
Q1 | $14.9M | Buy |
25,661
+509
| +2% | +$286K | 0.56% | 32 |
|
|
2023
Q4 | $13.4M | Sell |
25,152
-1,886
| -7% | -$913K | 0.6% | 30 |
|
|
2023
Q3 | $13.7M | Buy |
27,038
+5,070
| +23% | +$2.7M | 0.72% | 24 |
|
|
2023
Q2 | $11.5M | Buy |
21,968
+810
| +4% | +$437K | 0.46% | 41 |
|
|
2023
Q1 | $12.2M | Buy |
21,158
+186
| +0.9% | +$105K | 0.54% | 27 |
|
|
2022
Q4 | $11.5M | Sell |
20,972
-494
| -2% | -$262K | 0.53% | 29 |
|
|
2022
Q3 | $10.9M | Sell |
21,466
-2,444
| -10% | -$1.37M | 0.49% | 27 |
|
|
2022
Q2 | $13M | Sell |
23,910
-3,338
| -12% | -$1.84M | 0.5% | 27 |
|
|
2022
Q1 | $16.1M | Buy |
27,248
+5,785
| +27% | +$3.32M | 0.65% | 31 |
|
|
2021
Q4 | $14.3M | Buy |
21,463
+928
| +5% | +$579K | 0.61% | 35 |
|
|
2021
Q3 | $11.7M | Sell |
20,535
-11
| -0.1% | -$6.04K | 0.59% | 37 |
|
|
2021
Q2 | $10.4M | Buy |
20,546
+1,835
| +10% | +$866K | 0.52% | 40 |
|
|
2021
Q1 | $8.54M | Sell |
18,711
-433
| -2% | -$207K | 0.46% | 53 |
|
|
2020
Q4 | $8.92M | Sell |
19,144
-2,346
| -11% | -$1.1M | 0.52% | 40 |
|
|
2020
Q3 | $9.49M | Sell |
21,490
-1,582
| -7% | -$654K | 0.62% | 33 |
|
|
2020
Q2 | $8.36K | Buy |
23,072
+4,369
| +23% | +$1.46M | 0.1% | 42 |
|
|
2020
Q1 | $5.3K | Buy |
18,703
+4,180
| +29% | +$1.32M | 0.11% | 67 |
|
|
2019
Q4 | $4.72K | Buy |
14,523
+2,344
| +19% | +$711K | 0.1% | 81 |
|
|
2019
Q3 | $3.55K | Buy |
12,179
+4,605
| +61% | +$1.32M | 0.09% | 120 |
|
|
2019
Q2 | $2.22K | Buy |
7,574
+361
| +5% | +$99.4K | 0.06% | 151 |
|
|
2019
Q1 | $1.97M | Sell |
7,213
-2,868
| -28% | -$714K | 0.12% | 162 |
|
|
2018
Q4 | $2.26M | Buy |
10,081
+3,180
| +46% | +$746K | 0.15% | 152 |
|
|
2018
Q3 | $1.68M | Buy |
6,901
+1,673
| +32% | +$385K | 0.01% | 178 |
|
|
2018
Q2 | $1.08M | Buy |
5,228
+613
| +13% | +$130K | 0.01% | 218 |
|
|
2018
Q1 | $953K | Buy |
4,615
+49
| +1% | +$10.3K | 0.06% | 224 |
|
|
2017
Q4 | $867K | Buy |
4,566
+172
| +4% | +$33K | 0.06% | 228 |
|
|
2017
Q3 | $831K | Buy |
4,394
+469
| +12% | +$84.9K | 0.06% | 221 |
|
|
2017
Q2 | $685K | Buy |
3,925
+1,304
| +50% | +$219K | 0.05% | 228 |
|
|
2017
Q1 | $403K | Buy |
+2,621
| New | +$401K | 0.03% | 293 |
|
|
2014
Q1 | – | Sell |
-7,062
| Closed | -$786K | – | 295 |
|
|
2013
Q4 | $786K | Sell |
7,062
-485
| -6% | -$48.2K | 0.14% | 128 |
|
|
2013
Q3 | $681K | Buy |
7,547
+869
| +13% | +$78.6K | 0.12% | 173 |
|
|
2013
Q2 | $565K | Buy |
+6,678
| New | +$556K | 0.12% | 175 |
|
Other funds holding TMO
VCM
Freestone Capital Holdings's TMO Position: Q1 2026 in Review
Freestone Capital Holdings reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $195K and leaving 29,810 shares worth $14.7M. The position accounts for 0.44% of the portfolio, ranked #38.
Freestone Capital Holdings first reported a position in TMO in Q2 2013 and has held it in 40 quarters since. The position peaked at $17.5M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Freestone Capital Holdings held 29,810 shares of Thermo Fisher Scientific worth $14.7M as of Q1 2026.
- Freestone Capital Holdings sold 359 Thermo Fisher Scientific shares in Q1 2026, an estimated $195K.
- Thermo Fisher Scientific made up 0.44% of Freestone Capital Holdings's portfolio in Q1 2026, its #38 holding.
- Freestone Capital Holdings first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 40 quarters since.
- Freestone Capital Holdings's Thermo Fisher Scientific position peaked at $17.5M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.